Clinical Trial

Study on [14C]HMPL-453(FGFR Inhibitor) in Healthy Chinese Adult Male Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the absorption, metabolism and excretion in healthy Chinese male subjects after a single oral dose of \[14C\]HMPL-453
Trial Details
NCT Number NCT07644442
Lead Sponsor Hutchmed
Conditions Mass Balance Study
Enrollment 6 participants
Start Date 2025-02-26
Primary Completion 2025-03-14 (estimated)
Study Completion 2025-03-14 (estimated)
Updated on ClinicalTrials.gov 2026-06-12